Status:
COMPLETED
Hospital-acquired Pneumonia in Intensive Care Unit
Lead Sponsor:
Nantes University Hospital
Collaborating Sponsors:
Société Française d'Anesthésie et de Réanimation
Conditions:
Hospital Acquired Pneumonia
Ventilator-Associated Pneumonia
Eligibility:
All Genders
18+ years
Brief Summary
hospital-acquired pneumonia are a common disease in intensive care unit. The prevention, the diagnosis and the treatment of hospital acquired pneumonia are a frequent challenge. Nevertheless it seems ...
Detailed Description
The before period (phase 1) will consist of all consecutive patients admitted to the participating ICUs before the national guidelines publication concerning healthcare associated pneumonia. The seco...
Eligibility Criteria
Inclusion
- Age \> 18 years ; IGS-II score \> 15 ; Hospital stay \>= 3 days
Exclusion
- Community-acquired pneumonia, pregnant women, refusal to participate
Key Trial Info
Start Date :
September 15 2017
Trial Type :
OBSERVATIONAL
Allocation :
ACTUAL
End Date :
December 15 2018
Estimated Enrollment :
1850 Patients enrolled
Trial Details
Trial ID
NCT03348579
Start Date
September 15 2017
End Date
December 15 2018
Last Update
May 12 2020
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
CHU de NANTES
Nantes, France, 44093